ANIK

Anika Therapeutics, Inc.

Biotechnology · Biotechnology

$107.98 sample

-1.36 (-1.24%) 1D

Market cap

$78.8B

Price as of

2026-10-23

Latest filing

8-K · 2026-10-14

Alerts

8

Price$107.98 -7.40% 3M daily closessample

119.42107.98

2026-07-282026-08-192026-09-102026-10-012026-10-23

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 20INSInsider buy: Director
Oct 14SECForm 144 filed
Oct 07INSInsider sell: Chief Executive Officer
Sep 30INSInsider sell: Chief Executive Officer
Sep 23INSInsider sell: Chief Executive Officer
Sep 15INSInsider buy: EVP, Operations
Sep 10INSInsider sell: Chief Executive Officer
Sep 01INSInsider sell: EVP, Operations

Sign up to see the real ANIK record →

Company facts

SEC EDGAR registration

Name: Anika Therapeutics, Inc.
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: -46sample, -100 to +100
Reporting currency: USD

Who is positioning in ANIK

sample

Insiders: 14 insider transactions over 90 days, net selling, $719.5M
Congress: 1 members traded over 90 days
Institutions · 13F: 33 funds hold $723.1M
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$2.8B +9.4% y/y

Q4 2024Q3 2026

Inventory$1.7B +10.1% y/y

Q4 2024Q3 2026

Accounts receivable$1.3B +10.2% y/y

Q4 2024Q3 2026

Total debt$3.3B +10.2% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $17.2B -10.7% 3M
Sample peer B: $59.8B -5.3% 3M
Sample peer C: $58.2B -1.8% 3M
Sample peer D: $27.3B -6.0% 3M
Sample peer E: $67.9B -5.5% 3M